Table 1.
Sample number | ng/ml | MW (Da) | Δ To full length CCL18 | ||
---|---|---|---|---|---|
RHEUMATOID ARTHRITIS PATIENTS | |||||
8 | 41.1 | 7644.0 + H | 7614.5 + H | −185.4 | −185.3 |
7760.7 + H | 7729.6 + H | −68.7 | −70.2 | ||
7829.4 + H | 7799.8 + H | ||||
8036.9 + H | 8011.3 + H | +207.5 | +211.5 | ||
385 | 389.5 | 7764.6 + H | 7766.5 + H | −69.8 | −73.0 |
7834.4 + H | 7839.5 + H | ||||
8041.2 + H | 8046.0 + H | +206.8 | +206.5 | ||
402 | 92.01 | 7655.3 + H | −179.9 | ||
7765.9 + H | 7766.3 + H | −69.3 | −72.2 | ||
7835.2 + H | 7838.5 + H | ||||
8040.8 + H | 8043.9 + H | +205.6 | +205.4 | ||
2282 | 609.7 | 7747.9 + H | 7739.8 + H | −72.4 | −71.8 |
7820.3 + H | 7811.6 + H | ||||
8029.1 + H | 8026.9 + H | +208.8 | +215.3 | ||
OSTEOARTHRITIS PATIENTS | |||||
669 | 54.0 | 7766.6 + H | 7765.5 + H | −71.3 | −71.2 |
7837.9 + H | 7836.7 + H | ||||
8001.6 + H | 7999.5 + H | +163.7 | +162.8 | ||
8046.6 + H | 8042.8 + H | +208.7 | +206.1 | ||
1201 | 58.7 | 7761.0 + H | 7761.9 + H | −70.6 | −70.1 |
7831.6 + H | 7832.0 + H | ||||
7993.1 + H | 7994.9 + H | +161.5 | +162.9 | ||
8034.7 + H | 8036.7 + H | +203.1 | +204.7 | ||
1573 | 37.0 | 7762.7 + H | −71.6 | ||
7834.3 + H | |||||
7996.9 + H | +162.6 | ||||
8040.6 + H | +206.3 | ||||
2076 | 591.0 | 7719.5 + H | −72.4 | ||
7791.9 + H | |||||
8002.9 + H | +211.0 |
The concentration of CCL18 in each sample is indicated in ng/ml, as well as the mass obtained from each sample [MW (Da)] and the discrepancy of mass to full length CCL18 which is highlighted in bold (Δ to full length CCL18).